If you want to build a strong portfolio, then having a few blue chips in there could be a good starting point.
But which blue chip ASX 200 shares could be in the buy zone in April?
Let's take a look at a couple of high-quality options for investors to consider buying:
CSL Limited (ASX: CSL)
CSL could be a blue chip ASX 200 share to buy. It is one of the world's leading biotechnology companies, comprising the CSL Behring, CSL Vifor, and CSL Seqirus businesses.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases. Whereas CSL Seqirus is a leader in influenza vaccines and CSL Vifor is a global leader in iron deficiency and nephrology.
UBS is very positive on the company's outlook and expects double-digit earnings growth over the next three to four years.
As a result, the broker recently put a buy rating and $330.00 price target on the company's shares. This implies potential upside of 15% for investors from current levels.
Woolworths Limited (ASX: WOW)
Goldman Sachs thinks that Woolworths could be a blue chip ASX 200 share to buy.
As well as being Australia's largest supermarket operator, it owns Big W, Everyday Rewards, has a growing pet care business, and a collection of technology businesses such as Cartology and Quantium.
Goldman Sachs likes Woolworths due to its industry leadership and potential for more market share gains. The latter is expected to be driven by its loyalty program and omni-channel advantage. It also feels that concerns over inquiries into the supermarket industry are overdone.
The broker currently has a buy rating and $40.40 price target on its shares. This suggests potential upside of 22% for investors over the next 12 months from current levels.
